Ogrel 75mg Tablet 10`s

Description

Adult patients with established peripheral artery disease, myocardial infarction (from a few days to less than 35 days), or an ischemic stroke (from 7 days to less than 6 months) are candidates for secondary prevention of atherothrombotic events.